Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials.

Filion KB, El Khoury F, Bielinski M, Schiller I, Dendukuri N, Brophy JM.

BMC Cardiovasc Disord. 2010 Jun 3;10:24. doi: 10.1186/1471-2261-10-24. Review.

2.

Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.

Marik PE, Varon J.

Clin Cardiol. 2009 Jul;32(7):365-72. doi: 10.1002/clc.20604. Review.

3.

Heterogeneity in randomized controlled trials of long chain (fish) omega-3 fatty acids in restenosis, secondary prevention and ventricular arrhythmias.

Jenkins DJ, Josse AR, Dorian P, Burr ML, LaBelle Trangmar R, Kendall CW, Cunnane SC.

J Am Coll Nutr. 2008 Jun;27(3):367-78. Review.

PMID:
18838524
4.

n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.

Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J.

Am J Clin Nutr. 2006 Jul;84(1):5-17. Review.

5.

Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials.

Zhao YT, Chen Q, Sun YX, Li XB, Zhang P, Xu Y, Guo JH.

Ann Med. 2009;41(4):301-10. doi: 10.1080/07853890802698834.

PMID:
19148838
6.
7.

Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review.

Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV, Durrington PN, Higgins JP, Capps NE, Riemersma RA, Ebrahim SB, Davey Smith G.

BMJ. 2006 Apr 1;332(7544):752-60. Epub 2006 Mar 24. Review.

9.

N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials.

Bucher HC, Hengstler P, Schindler C, Meier G.

Am J Med. 2002 Mar;112(4):298-304.

PMID:
11893369
10.

Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected].

Casula M, Soranna D, Catapano AL, Corrao G.

Atheroscler Suppl. 2013 Aug;14(2):243-51. doi: 10.1016/S1567-5688(13)70005-9. Review. Erratum in: Atheroscler Suppl. 2014 Mar;233(1):122.

PMID:
23958480
11.

Omega-3 fatty acids in the prevention-management of cardiovascular disease.

Simopoulos AP.

Can J Physiol Pharmacol. 1997 Mar;75(3):234-9. Review.

PMID:
9164707
12.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

13.

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

Vrecer M, Turk S, Drinovec J, Mrhar A.

Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77.

PMID:
14692706
14.

Omega-3 polyunsaturated fatty acids and cardiovascular diseases.

Lavie CJ, Milani RV, Mehra MR, Ventura HO.

J Am Coll Cardiol. 2009 Aug 11;54(7):585-94. doi: 10.1016/j.jacc.2009.02.084. Review.

15.

Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis.

Gapinski JP, VanRuiswyk JV, Heudebert GR, Schectman GS.

Arch Intern Med. 1993 Jul 12;153(13):1595-601.

PMID:
8323422
17.

Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.

Kwak SM, Myung SK, Lee YJ, Seo HG; Korean Meta-analysis Study Group.

Arch Intern Med. 2012 May 14;172(9):686-94. doi: 10.1001/archinternmed.2012.262. Review.

PMID:
22493407
18.

Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis.

Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B.

Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):808-18. doi: 10.1161/CIRCOUTCOMES.112.966168. Epub 2012 Oct 30. Review.

19.

[Health effects of fish oil and fish oil supplements: consumption advice sustained].

Iglesias del Sol A, Smulders YM.

Ned Tijdschr Geneeskd. 2006 Sep 23;150(38):2069-71. Dutch.

PMID:
17036855
20.

[Omega-3 fatty acids, fish, fish oil and cardiovascular disease--a review with implications to Israeli nutritional guidelines].

Eilat-Adar S, Lipovetzky N, Goldbourt U, Henkin Y.

Harefuah. 2004 Aug;143(8):585-91, 622, 621. Review. Hebrew.

PMID:
15523812

Supplemental Content

Support Center